Board of Directors

  David Hill Julia Levy
Ron Hosking Alan Ryley Rochelle Stenzler
Alan Torrie

David Pattenden

LLD, Chairman of the Board

Dr. David Pattenden most recently served as the CEO of the Ontario Medical Association (“OMA”) for 11 years. When David arrived at the OMA in 1994, he initiated a profound change in the OMA's vision, culture, management and operation. Prior to leading the OMA, David had a successful and varied career in academia, law and business. He is the past CEO and Chairman of the board of UTDC Inc. (Division of Lavalin & Bombardier ). He spent many years working in more than 20 countries, negotiating complex agreements with governments, unions and private sector organizations. David has 5 degrees from Queens University and was formerly on the faculty of their Law School, and their Commerce and MBA programs. He was an advisor to the Federal government on the NAFTA negotiations and participant in numerous trade missions. He is presently involved at Queen's University, in both the Faculty of Medicine (Assistant Professor and member of the Cancer Review Committee) and the Faculty of Law (Chair of Law Steering Committee), as well as being on the Board of Directors of the Queen's teaching hospital and being recently elected to the Board of Trustees of the University.

Horizonatal Rule
  About CynapsusLine SeperationRelivar ProductLine SeperationAPL-130277 ProductLine SeperationInvestor RelationsLine SeperationContact & LegalLine Seperation

Copyright 2010, Cynapsus Therapeutics Inc. All rights reserved.